treatment for this type of cancer, especially when locally advanced, often uses radiation therapy.
Radiation therapy effcacy is known to be dependent on oxygen status. 2 Therapeutic treatment is less effcacious in patients with poorly vascularized/hypoxic tumors, and it is therefore desirable to identify and target such patients for special treatment. 1, 3, 4 To date, some correlations between oxygenation status in human solid tumors and tumor response to therapy have been evaluated, 5 but the mechanisms associated with tumor oxygenation and blood fow variation during chemo-radiation are poorly understood. 6 Studies including head and neck carcinoma have exhibited an increase of positive response in tumors with high pretreatment oxygenation compared to poorly oxygenated tumors. 6, 7 However, in these studies some well-oxygenated tumors failed to respond, while some hypoxic tumors responded, possibly due to changes in tumor oxygenation during treatment. One factor that modulates tumor tissue oxygenation is blood fow. Recent magnetic resonance imaging MRI and computed tomography CT investigations have demonstrated signifcant blood fow changes during therapy and have suggested that these early blood fow changes may have prognostic value. [8] [9] [10] Clearly functional assessment of blood oxygenation and fow variation during the early weeks of treatment holds potential for assessment of therapy effcacy/outcome. Moreover, blood fow and oxygenation changes during therapy may enable clinicians to adjust treatment dosage.
Several methods exist for measurement of oxygenation and blood fow. The oxygen-sensitive microelectrode needle method provides a "reference standard" for measurement of tumor oxygenation. 5, 11 However it is invasive and inconvenient for clinical use. 12 Thus, there remains a need for reliable noninvasive techniques that measure tumor hemodynamic responses. Tumor blood fow measurements are particularly attractive for this application, since blood fow has been correlated with tumor oxygenation. 2, 13, 14 Blood fow has been measured in clinical studies by several imaging modalities, 12, 15, 16 including positron emission tomography PET, dy- 10, 17 namic computed tomography CT, dynamic contrast-8,9,18 MRI enhanced magnetic resonance imaging DCE-MRI, with spin labeling, 19 and ultrasound color Doppler. 20 Some of these techniques require contrast agent administration PET, DCE-MRI or ionizing radiation CT; others are surface sensitive laser Doppler, 21 and most are diffcult to employ routinely with high throughput. The near-infrared diffuse optical methods presented here offer a noninvasive, rapid, portable, and low-cost alternative for repetitive bedside monitoring of tumor therapies.
The concept of noninvasive repetitive blood fow and oxygenation measurements is particularly attractive in the context of recent research on vascular modulating and antiangiogenic agents, which affect the response and sensitivity of tumors to chemotherapy and radiotherapy. [22] [23] [24] The work of Folkman 25 and other investigators, for example, has demonstrated potential therapeutic benefts of targeting tumor vasculature and tumor angiogenesis, and clinical trials of the anti-vascular endothelial growth factor VEGF monoclonal antibody bevacizumab have confrmed this new therapeutic paradigm. [26] [27] [28] [29] To facilitate clinical translation of agents that target tumor vasculature, an ability to frequently assess tumor vessel blood fow and oxygenation with repetitive measurements is desirable, and potentially might lead to a means for individualized radiation therapy.
Diffuse optical spectroscopy and imaging has very recently emerged as a candidate for tumor therapy monitoring. In a case study, Jakubowski et al. 30 showed that the greatest breast tumor physiological hemoglobin concentrations, water content, lipid content changes occur within the frst week of neoadjuvant chemotherapy. In a similar vein, combined diffuse optical imaging with ultrasound localization by Zhu et al. 31 demonstrated changes in the heterogeneous hemoglobin distribution in breast tumors during chemotherapy, and in a case study with comparison to DCE-MRI, Choe et al. 32 used the diffuse optical imaging technique to quantify optical contrast of breast tumors during chemotherapy.
In this contribution, we use noninvasive diffuse optical methods to investigate tumor responses to chemo-radiation therapy in a new class of patients with head and neck tumors. In contrast to previous work, our instruments concurrently incorporate diffuse correlation spectroscopy DCS as well as the more traditional diffuse refectance spectroscopy DRS. The DCS methodology permits assessment of tumor blood fow before and during radiation therapy, and the DRS measurements enable quantifcation of the concentration of tissue chromophores such as oxy-and deoxyhemoglobin. The DCS method detects moving blood cells, and has been successfully employed in animal studies, 33 for example, burn depth estimation in pigs 34 and cerebral blood fow in rats. 35, 36, 70 Very recently, the technique has been applied in human brain, 37, 38 human muscle functional studies, 39 and in breast cancer patients. 40 Moreover, validation of DCS in some cases has been provided by comparison to the power Doppler ultrasound, 41 laser Doppler, 42 and arterial spin labeled MRI. 43 DRS provides information about oxygen saturation and total hemoglobin concentration and has been widely used in tumor and normal tissue functional studies. [44] [45] [46] [47] [48] [49] [50] [51] [52] The investigation of a limited number of patients in this pilot study reveal that weekly relative blood fow rBF, tissue oxygen saturation StO 2 , and total hemoglobin concentration THC kinetics exhibit different patterns for different individuals, including on average a signifcant early increase in rBF followed by a signifcant decrease in rBF. The averaged StO 2 exhibits an increase in the early weeks, while averaged THC tends to decrease continually during therapy.
Methods

Basic Principles of Diffuse Photon Correlation Spectroscopy
Near-infrared photons diffuse through thick living tissues. 33, 53 When diffusing photons scatter from moving blood cells, they experience phase shifts that cause the intensity of detected light on the tissue surface to fuctuate in time. These fuctuations are more rapid for faster moving blood cells. Therefore, one can derive information about tissue blood fow far below the tissue surface from measurements of temporal fuctuations impressed on diffusing light. Details of the diffuse photon correlation method can be found elsewhere. 34, 35, [54] [55] [56] Briefy, the normalized temporal intensity autocorrelation function of the diffused light,
is measured on the tissue surface. Here, Ir , t is the diffuse light intensity at position r, and time t , ... denotes a time average, and is the autocorrelation time delay. The electric feld of the diffusing light Er , t is also characterized by a temporal autocorrelation function, G 1 r , = E * r , Er , t + . Usually it is derived from measurements of g 2 r , using the Siegert relation, 57 g 2 r , =1+ G 1 r , 2 / I 2 =1+ g 1 r , 2 ; here is a constant that depends on source and detection experimental parameters such as the number of detected speckles, and g 1 r , = G 1 r , / I is the normalized feld correlation function.
The electric feld autocorrelation function traveling through dynamic turbid media obeys a diffusion equation. 34, 54, 58 Data collected in the refectance geometry are readily analyzed by solving this diffusion equation using, for example, the semi-infnite medium approximation. 59 The analytical form of the autocorrelation function within the semiinfnite approximation can be obtained from the image source approach following Kienle and Patterson. 60 In particular, for semi-infnite homogeneous fuctuating turbid medium and for point sources of the form Sr = S 0 r, the electric feld autocorrelation function on the tissue surface is Fig. 1 Normalized temporal diffuse electric feld autocorrelation function g 1 r , = G 1 r , / I data for patient 2 P-2 before, and 1 week after radiation therapy. The faster temporal decay in the autocorrelation curve corresponds to an increased blood fow.
Using the Nelder-Mead Simplex algorithm in Matlab Mathwork, Inc. software, the fow parameter and the experimental constant are obtained by minimizing the difference between the predicted analytical form of the autocorrelation function in the refectance geometry g 1,th r , i , and the measured autocorrelation function g 1,exp r , i , i.e., 2 = i g 1,th r , i − g 1,exp r , i 2 . The exact form of the autocorrelation function depends on measurement geometry as well as on tissue optical properties. Here we report rBF. rBF is a exp− kr 1 exp− kr 2 blood fow index defned as the blood fow parameter
relative to its pretreatment value in percent units with 100% , r 1 r 2 implying no change. rBF is thus unitless.
Blood Oxygen Saturation and Total Hemoglobin Concentration Measurements
The concentrations of oxy-, deoxy-, and total hemoglobin C HbO 2 , C Hb , THC, are extracted using DRS data with multiwavelength and multisource/detector separations . A multiwavelength ftting algorithm was applied to directly extract C Hb , C HbO 2 , and the scattering coeffcient, assuming an absorption due only to oxy-and deoxyhemoglobin, a = i C i i = Hb , HbO 2 . Here, i is the extinction coeffcient of the i'th chromophore at a given wavelength and is obtained from the literature. 64 It is also assumed that scattering follows a Mie-type behavior 65 in the near-infrared spectral window, absorption and scattering coeffcients of the underlying medium. These can be obtained from DRS measurements, k o is the wavenumber of light in the medium, and r 1 r 2 is the distance between source image source and the detector on the surface. Detailed explicit forms of these solutions are given in the Appendix. = D B characterizes temporal fuctuations in the medium due to scatterer motions such as blood fow. Here, is a factor representing the probability that a scattering event in tissue is from a moving scatterer such as a red blood cell. It is proportional to tissue blood volume fraction. D B is an "effective" diffusion coeffcient for the blood cells. It should be noted that the effective diffusion coeffcient need not and is generally not be the "thermal" Brownian motion predicted by Einstein; 61 nonthermal random forces in a fxing B allows more robust ftting with our multiwavelength ftting algorithm. 66 There are very few quantitative measurements of parameter B and its value ranges between 0.3 and 1.5. [67] [68] [69] We assumed a value of B = 0.8. Varying this value by 50% resulted in less than 5% variation in the quantifcation of scattering coeffcients and other physiological parameters. In the vasculature can also give rise to diffusive particle motions. It is assumed herein that measured relative changes of D B are proportional to relative changes in tissue blood fow. Larger implies faster electric feld or intensity autocorrelation function temporal decay and higher blood fow Fig.1 . A detailed microscopic model relating tissue blood fow to 2 = R m the analysis, we minimized s 2 to extract hemoglobin concentrations and , a , is not available; it is the subject of current research. Never-, theless, the proportional relationship has been verifed [41] [42] [43] − R c , , a , against a variety of traditional blood fow/perfusion measurement methods in a variety of different physiological contexts. We adopt this relationship as a fundamental assumption in our experimental approach. We note here that another related microscopic interpretation, which takes "bulk" blood displacement into account, explicitly has been proposed recently in the context of laser Doppler fowmetry.
62,63
s A. R m is the measured diffuse refectance and R c is the calculated diffuse refectance in the semi-infnite geometry. An explicit form for R c is given in the Appendix. After obtaining oxy-and deoxyhemoglobin concentrations, one readily derives total hemoglobin concentration THC, and blood oxygen saturation and multidistance ftting algorithm extensively with Intralipid titration, and we have found good correlation between extracted and expected optical properties.
Instrumentation
Diffuse correlation spectroscopy instrument
We constructed a portable four-channel system for use in the clinical study Fig. 2a . The instrument used a long coherence length laser Crysta Laser, Nevada operating at 785 nm, an optical switch DiCon Fiberoptics, California, four photon-counting fast avalanche photodiodes Perkin-Elmer, Canada, and a custom built four-channel autocorrelator board Correlator.com, New Jersey. The source light delivered to the neck was switched between two multimode source fbers. Single-mode detector fbers were used to collect the light. All fbers were inserted into a soft pad so the operator could place this single hand-held probe onto the patient's neck Fig. 2b . Photons transmitted into the neck were collected by the single-mode detector fbers in refectance. The shortest and largest separations between source and detector fbers were 2 and 3 cm, respectively. When our signals were small, we increased the number of fbers at large separations to increase the measurement signal-to-noise SNR ratio. 70 In the ftting process, the largest separation 3 cm was used to extract blood fow parameters. Typically the average photon penetration depth into the tissue is one-third to one-half of the source-detector separation;
71,72 thus, we believe the signal originates largely from superfcial neck tumor nodes. optical switches were used to switch the colors and source fber positions. The light was collected by two APDs and two PMTs only one source, one detector fber, and one channel of the instrument is shown for simplicity. Amp=amplifer, BPF=bandpass flter, LPF=low-pass flter, IQ=in-phase and quadrature demodulators, and A/D=analog-todigital converter. b Optical probe: two detector fber bundles and four source fbers are arranged with shortest separation of 1.8 cm, and longest separation of 3 cm. S1, S2, S3, and S4 are source fbers and Dl and D2 are detector fbers.
Diffuse reflectance spectroscopy instrument
A four-channel frequency domain instrument was used in the clinical study Fig. 3a . The details of the instrument are described elsewhere. 73, 74 Briefy, the instrument uses 690-, 785-, and 830-nm laser diodes Thorlabs Incorporated, New Jersey, each of which were modulated at 70 MHz. Two 1 4 optical switches DiCon Fiberoptics, California were used to switch the wavelength and source fber positions. The light was collected by two avalanche photodetectors APD, Hamamatsu, C5331-04 and two PMTs R928, Hamamatsu, which were all coupled onto the tissue surface via 3-mm fber bundles. After amplifying and fltering, signals from the detectors were mixed with a reference signal in an in-phase and in-quadrature IQ demodulator Mini-Circuits, New York, thus generating the I and Q signal components. After the lowpass flter, the dc components of the I and Q signals were used to calculate the amplitude and phase of the diffuse photon density waves DPDWs that passed through the tissue. In the measurements, an optical probe using two detector fber bundles and four source fbers were employed Fig. 3b . Source and detector fbers were arranged such that at least four different source detector separations 1.8, 2.2, 2.6, and 3 cm were used for each patient to quantify oxygenation parameters with fdelity. To calibrate the unknown sourcedetector coupling and to normalize the instrument response, the symmetry of the source-detector fbers and an Intralipid solution with known optical properties were used see the Appendix. The absorbance of the ink was determined and calibrated using an Ocean Optics spectrometer; for scattering, we used the well-known formula for Intralipid from the literature. 
Measurement Protocol
The study protocol was approved by the review board of human subjects of the University of Pennsylvania and informed consent was obtained from all patients. In our measurements, CT and MRI scans provided additional information about the location and size of each tumor. DCS and DRS measurements were carried out consecutively. The protocol Fig. 4 consisted of preradiation measurements as baseline data. Subsequently, weekly measurements were carried out for each individual until his/her treatment was completed. Each patient received daily fractionated irradiation from Monday through Friday, and the optical measurements were completed just before treatment began each week. Patients were concurrently treated with weekly Carboplatin area under the curve =2 mg/ml min and Paclitaxel 30 mg/ m 2 . Daily fractionated radiotherapy was administrated with an intensitymodulated parotid-sparing radiotherapy technique. A simultaneous in-feld boost prescription technique was used prescribing 7040 centiGray cGy in 220 cGy per fraction over 32 fractions to both primary and gross neck disease. The overall treatment time was about 6.4 weeks. Standard response evaluation criteria in solid tumors RECIST 75 response criteria was applied to classify tumor responses. A responder is defned as a patient with no evidence of residual cancer in the neck dissection specimen at the end of treatment. Formal assessment of treatment response was conducted 6 weeks after completing therapy. Postchemoradiotherapy neck dissections were evaluated using pathologic response.
The optical measurements were carried out by three different operators to assess the repeatability of the method. Each operator placed the probe onto the neck and arm muscle for control purposes three times. The data reported in this work represent an average ± standard error of the three operator measurements. Placement of the probe and consecutive measurements of both blood fow and oxygenation took 15 min in total, including the different observers. The largest nodal mass was selected for weekly optical measurements. Palpation and measurements with a ruler were the main tools used for identifying tumors during therapy. A trained radiology nurse was present during each measurement to assist in the identifcation of tumors. Tumor locations were measured with the ruler and systematically noted with respect to the ear and chin of the patients. Diffuse optical measurements placed the probe at the same center location of each tumor, and the measurements were repeated at that particular location. The repeatability error was small 5%. No obvious trends with respect to operators were found. Only the diffuse optical method was available for weekly measurements. Structural images such as from CT were available at pretherapy only.
Statistical Analysis
All statistical analyses were performed using Matlab Mathwork, Incorporated. Nonparametric procedures were applied, because of some deviations from a normal distribution. Paired comparisons were performed using the Wilcoxon MannWhitney U test, two-tailed, to identify trends and substantial changes. Differences were considered signifcant for p 0.05.
Results
A total of eight patients were examined weekly. The patient and tumor characteristics are given in Table 1. Tables 2-4 summarize data from tumor t and arm muscle m of eight patients labeled P-1, P-2 , . . . P-8. Table 2 exhibits rBF % at the end of week 1, week 2, week 3, and week 4 of chemoradiation therapy. The pretreatment value at week 0 was defned as 100% in all patients. Similarly, Tables 3 and 4 summarize weekly changes of StO 2 % and THC M, respectively. For patient 2 P-2, optical measurements were stopped at the end of third week because the tumor was no longer palpable. For patient 3 P-3, optical measurements could not be acquired after the third week of the therapy because of scheduling diffculties. It is clear from the tables that our individual results varied greatly. This has also been the case in animal experiments 16 and clinical trials 2 employing radiation therapy; apparently, this variation is only partly a result of methodological factors such as differences in probe handling and positioning on the tissue.
A representative optical response of one of the complete responders is given in Fig. 5 corresponding to P-l. In this case, rBF increased in the early weeks, and a subsequent decrease followed; StO 2 exhibited a small decrease with a subsequent small increase at the second week; and THC exhibited a continuous drop-off during therapy. Patient 8 P-8, a partial responder, was excluded from the statistical analysis, since P-8 exhibited substantially different tumor hemodynamic response during the therapy Fig. 6 ; in this case rBF exhibited a continual increase, while StO 2 and THC also tended to increase over the course of treatment. For this patient, pretherapy CT showed a large necrotic nodal mass measuring 5 cm diam, and the tumor was still relatively large and palpable at the end of the therapy. Postsurgical pathology confrmed the existence of residual tumor, and so the patient was considered to be a partial responder. Figure 7 shows the trend of rBF, StO 2 , and THC averaged over patients 1 to 7 P-l, P-2, ... P-7. A signifcant p = 0.0002 increase 52.7± 9.7 % was observed in rBF during the frst week of the therapy Fig. 7a . Our data also showed that tumor blood fow decreased 42.4± 7.0 % , p = 0.007 during the second week of the therapy and remained low in the third and fourth weeks. The changes measured in the third p = 0.52 and fourth p = 0.92 weeks were not signifcant. Arm muscle levels had a tendency to decrease in the early weeks, but overall the changes were not statistically signifcant p = 0.54, 0.25, 0.30, and 0.19, respectively. Our observations are in reasonable agreement with other studies using different methods. Mantyla et al. 16 reported absolute blood fow changes in 43 patients including squamous cell carcinoma of head and neck; a 56% mean increase at the end of the frst week, and a statistically signifcant decrease was observed at the end of the second week using the 133 Xe clearance method. MRI studies have also reported an enhancement in blood fow after the frst week of the therapy; 8, 9, 18, 19, 77 De Vries 9 quantifed the blood fow changes and found a statistically signifcant increase of 21% after the frst week and 25% after the second week of the radiation therapy in patients with rectal carcinoma. 
Average Relative Blood Flow Response
Nu mber of Weeks
(c)
The biologic signifcance of an increase in tumor blood fow is not well understood. It is possible that the increase may improve tumor oxygenation and therefore tumor radiosensitivity. 1, 2, 8 The mechanism for such a favorable response might be refected in the observations of Sonveaux et al. 78 These investigators concluded that clinically relevant doses of radiation elicit a vascular stress response with increased secretion of tumor endothelial nitric oxide, which in turn can cause vasodilation, increased blood fow, and increased vessel permeability. Alternatively, this early increase in blood fow may refect a corresponding decrease in the interstitial fuid pressure affecting the tumor vessel distensibility, and consequentially, blood fow. 79 Preferential damage to a subpopulation of oxygenated cells may lower the inter-−1 during chemo- Fig. 8 Tumor scattering coeffcient changes cm s radiation therapy for an average of patients P-1 to P-7.
stitial pressure on microvessels within the tumor, thus opening capillaries and increasing tumor blood microcirculation. 80 This effect can facilitate improved chemotherapy delivery to tumors as has been demonstrated in preclinical xenograft tion has also been observed in tumor tissue during radiation therapy. 16, 21 Therefore, it should be noted that diffuse optical models. creased tumor oxygenation; however, relatively large doses of radiation can also damage tumor capillaries and reduce tumor oxygenation. 84 Clinical studies on tumor oxygenation during radiation are very scarce and are only limited to case reports. 11 Quantitative pO 2 measurements during the radiotherapy were frst done by Badib and Webster. 85 At weekly intervals, a progressive increase in tumor oxygenation was observed. Bergsjo and Evans 86 reported a slight increase in the average oxygenation of tumors of the uterine cervix in the early phase within 2 weeks period of the therapy. In a recent study, 25 metastatic head and neck tumor nodes were investigated during chemoradiation therapy. 11 A clear increase was observed at the end of second week, and overall pO 2 values were decreased at the end of the therapy.
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Average Tissue Oxygen Saturation Response
Average Total Hemoglobin Concentration Response
Average THC exhibited a continuous decrease during therapy 
Discussion
We have demonstrated the feasibility of diffuse optics for chemo-radiation therapy monitoring in head and neck cancer patients. In this section, we outline some of the limitations of the current approach. We also indicate variations in approach that will facilitate future improvement. In our measurements, it is possible that different observers may have applied different probe-tissue pressure and introduced different probe positioning; both of these effects can induce variations in quantifcation. These variations were quantifed and reported as error bars in the fgures. In addition, the head and neck region consists of different anatomical tissues such as muscle and fat, which can vary across patients. Thus the semi-infnite homogeneous medium approximation is unlikely to be exactly valid. For example, our multidistance ftting scheme uses short separations = 1.8, 2.2, 2.6 cm and one long separation =3 cm. On the other hand, rBF was extracted using the longest separation =3 cm only. Therefore, StO 2 and THC measurements are likely to be more affected by near surface tissues compared to blood fow measurements. Nevertheless, we have confned to employing the semi-infnite approximation because it simplifes our analysis enormously and enables us to extract trends from our weekly measurements. Better quantifcation, as well as increased ability to distinguish different tissue structure tumor, muscle, fat, can be obtained from similar measurements using larger numbers of sources and detectors, and also by image segmen- Number of Weeks tation based on other available anatomical information. 31, 89 However, in practice the larger number of sources and detectors also introduces some diffculty interfacing the probe to the tissue. From experience we have found that the relatively large probe having many fbers had disadvantages, especially when trying to contact all fbers to the tissue surface with equal pressure. Therefore, a bulkier single probe containing many blood fow and oxygen saturation fbers was avoided. In the future, a better probe design may enable better quantifcation by preserving good probe-tissue contact. Additional benefts may be obtained by comparing the tumor to surrounding healthy tissue. Line scanning, as suggested by Jakubowski et al., 30 across the tumor would be more favorable during therapy monitoring; however, it was not possible in our case due to time constraints. Ultimately, line scanning and/or imaging the whole tumor with rapid data acquisition should generate a richer dataset. Although radiation therapy science has improved with recent technological developments to better optimize beam localization in the tumor, normal tissue damage near the tumor may still exist. In the long term, it would be interesting to coregister radiated volume with the diffused photon path to better discriminate radiation effects on normal and tumor tissues.
Finally, limitations such as uncertainties in tumor boundaries can potentially be eliminated by coregistering the diffuse optical methods with other structural imaging modalities such as hand-held ultrasound 31 and MRI, 89, 90 and by correcting for tumor shrinkage. Since CT is available only at pretherapy, adding a structural imaging methodology such as ultrasound into our protocol in the future would enable us to assess tumor size changes weekly, during therapy. Tissue heterogeneity effects may also be investigated with imaging techniques. 31, 89 In this study we have primarily focused on the changes of hemodynamic responses of the tumor as a result of a perturbation, i.e., chemo-radiation therapy. Because assessment of early response could potentially improve treatment outcome, the results we have presented encourage one to focus on early weeks. Indeed, as suggested by Jakubowski et al., 30 one can carry out more frequent measurements e.g., on a daily basis to extract trends within the frst week. It might even be interesting to focus on pretreatment conditions, possibly targeting patients for special protocols. In its current form, however, normalization of the blood fow to the frst week precludes use of DCS before therapy begins. Extraction of absolute measures of blood fow will require better absolute calibration. In principle, DCS can be calibrated with other techniques at particular physiologic conditions, as was done recently with the and oxygenation changes observed here suggest the potential utility of daily measurements during the frst two weeks of treatment. Due to very low accessibility of most other diagnostics methods, diffuse optical techniques have advantages for daily-based therapy monitoring.
Conclusion
Several techniques such as MRI, CT, and PET have been employed for monitoring tumor therapies, but the desire for a noninvasive, real-time bedside monitoring device makes diffuse optical techniques very attractive for clinical applications. Future clinical applications might also include concurrent use of optical methods with established modalities. 31, 89, 90 With possible clinical requirements in mind, we quantify tumor rBF, StO 2 , and THC changes noninvasively during chemo-radiation therapy using diffuse optical spectroscopies. These techniques do not require contrast agent administration and are suitable for bedside examinations with rapid data acquisition. Our preliminary data show that patients exhibit signifcant changes of rBF, StO 2 , and THC, even in the frst two weeks of treatment. In one patient P-8, a different trend was observed with a preliminary indication that it coincided with a different treatment outcome. This anecdotal observation should be further studied with better statistics. At this point, more statistics are required for assessment of the prognostic value of these new methods. During treatment, different types of functional parameters may have different sensitivity to the therapy for different individuals. In other words, one parameter alone may not be a good predictor for a particular patient; multiparameter analyses such as those we present potentially enable clinicians to better discriminate and predict responses, and to continuously re-evaluate the treatment plan according to the probabilistic sensitivities of various hemodynamic functional parameters. Such experiments should be a next step.
APPENDIX
A.1 Field Autocorrelation Function in Explicit Form
It has been shown that the electric feld autocorrelation func- 43 but further work remains. Our results suggest early clinical tumor response to radiation therapy can be detected and quantifed by diffuse optical 3 spectroscopies. The data clearly exhibit signifcant changes within two weeks of therapy. The early fow changes may be signifcant in affecting drug delivery effcacy and/or tumor oxygenation during chemo-radiation therapy, and the early tumor oxygenation changes may be related to tumor response. The responses of patients P-1 to P-7 were similar, and different from that of the partial responder patient P-8, but our statistics are not suffcient to draw signifcant physiological conclusions. Since a primary aim of therapy diagnostics is to predict the response as early as possible, the early blood fow the turbid medium in time interval . The exact form of the autocorrelation function depends on measurement geometry, tissue optical properties, as well as on the model that describes the nature of the scatterer motion. The mean squared displacement in the "effective" diffusion model is r 2 =6D B . In the main text we have set = D B . The mean squared displacement in the random fow model is r 2 = v 2 2 , where v 2 is the mean square velocity of the scatterer in the vasculature. We adopt the effective diffusion model for our analysis.
For a point source Sr = S 0 r, the solution for a semialong the tissue surface, z 0 is the effective depth of the source, infnite geometry can be obtained using an image source approach following Kienle and Patterson. 60 It is given by Eq. 
A.2 Diffuse Reflectance in Explicit Form
The photon fuence rate also satisfes a diffusion equation. In the frequency domain and using a point source that is intensity modulated sinusoidally with modulation frequency Here, ij is the distance between the i'th source and j'th dePhysics Division of Hospital of the University of Pennsylvania for providing CT, MRI, and PET scans of our head and neck patients.
